Timber Pharmaceuticals Inc. (AMEX: TMBR) started the day on December 02, 2021, with a price decrease of -4.57% at $0.40. During the day, the stock rose to $0.42 and sunk to $0.39 before settling in for the price of $0.42 at the close. Taking a more long-term approach, TMBR posted a 52-week range of $0.42-$3.65.
The Healthcare sector firm’s twelve-monthly sales growth has been 48.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 67.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 89.20%. This publicly-traded company’s shares outstanding now amounts to $63.27 million, simultaneously with a float of $32.23 million. The organization now has a market capitalization sitting at $25.21 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6712, while the 200-day Moving Average is $1.2005.
Timber Pharmaceuticals Inc. (TMBR) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Timber Pharmaceuticals Inc.’s current insider ownership accounts for 5.50%, in contrast to 4.90% institutional ownership. According to the most recent insider trade that took place on Nov 23, this organization’s Chief Medical Officer bought 10,000 shares at the rate of 0.47, making the entire transaction reach 4,700 in total value, affecting insider ownership by 10,000. Preceding that transaction, on Nov 23, Company’s Director bought 15,000 for 0.46, making the whole transaction’s value amount to 6,900. This particular insider is now the holder of 15,000 in total.
Timber Pharmaceuticals Inc. (TMBR) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 4/29/2020, the organization reported -$1.34 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.84) by -$0.5. This company achieved a return on equity of -2,020.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Timber Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 89.20%.
Timber Pharmaceuticals Inc. (AMEX: TMBR) Trading Performance Indicators
Let’s observe the current performance indicators for Timber Pharmaceuticals Inc. (TMBR). It’s Quick Ratio in the last reported quarter now stands at 1.80. The Stock has managed to achieve an average true range (ATR) of 0.05. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 31.52.
In the same vein, TMBR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.19.
Technical Analysis of Timber Pharmaceuticals Inc. (TMBR)
If we take a close look at the recent performances of Timber Pharmaceuticals Inc. (AMEX: TMBR), its last 5-days Average volume was 2.46 million that shows plunge from its year to date volume of 4.33 million. During the previous 9 days, stock’s Stochastic %D was recorded 6.46% While, its Average True Range was 0.0474.
Raw Stochastic average of Timber Pharmaceuticals Inc. (TMBR) in the period of the previous 100 days is set at 0.71%, which indicates a major fall in contrast to 2.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 94.23% that was higher than 83.90% volatility it exhibited in the past 100-days period.